We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Veeva Systems, Inc. (VEEV - Free Report) recently announced that global pharmaceutical company Boehringer Ingelheim has decided to make a rapid shift to digital engagement standardizing on Veeva CRM Engage Meeting. This is expected to accelerate more valued virtual interactions between Boehringer Ingelheim’s global field organization and healthcare providers (“HCPs”). Notably, the Veeva’s CRM solution helped Boehringer Ingelheim host more than one million remote meetings in just a year.
The standardizing of Veeva CRM Engage Meeting by Boehringer Ingelheim builds upon the successful utilization of Veeva CRM for multichannel engagement. Also, the company uses Veeva Vault PromoMats and Veeva Vault MedComms to make compliant digital content used by field teams during engagements with HCPs.
The recent development is likely to boost Veeva’s CRM portfolio.
More in the News
Boehringer Ingelheim leverage Veeva CRM Engage Meeting to simplify compliant virtual meetings, extending the reach and productivity of its field team as well as provide them more flexibility to connect with HCPs anytime, anywhere. The adoption of Veeva CRM solution will enable Boehringer Ingelheim to adapt to new market dynamics and connect with the HCPs at the right time through the accurate channels.
Per management of Boehringer Ingelheim, Veeva CRM Engage Meeting provides an improved way to connect with doctors and provide them with the information related to new therapeutic options.
Notably, Veeva CRM Engage Meeting helped Boehringer Ingelheim convey more information to HCPs and strengthen relationships by doubling the medical sales representatives’ average meeting duration to 20 minutes during the past year.
Notable Developments
In March 2021, Veeva announced that it had its first patient complete an electronic consent for an early phase clinical trial at the Crofoot Research Center using Veeva eConsent, a MyVeeva for Patients application developed on Veeva Clinical Network.
In February 2021, Veeva announced that Veeva CRM and Veeva Vault PromoMats were adopted by Reckitt Benckiser, a leading provider of consumer hygiene, health, and nutrition products to accelerate its global digital transformation. Veeva CRM and Vault PromoMats enable Reckitt Benckiser to incorporate multichannel engagement and content to progress its commercial strategy as well as accelerate digital excellence around the globe.
Industry Prospects
Per a report by Grand View Research, the global healthcare CRM market size is expected to reach $17.8 billion by 2025 at a CAGR of 9.1%. Demand for operational efficiency in healthcare organization and adoption of virtual care is driving the market.
Price Performance
Shares of the company have gained 89.4% in a year’s time compared with the industry’s growth of 109.9%.
Arlo Technologies has a projected long-term earnings growth rate of 48%.
Calix has a projected long-term earnings growth rate of 39%.
Covetrus has an estimated long-term earnings growth rate of 21%.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Image: Bigstock
Boehringer Ingelheim Adopts Veeva's (VEEV) CRM Solution
Veeva Systems, Inc. (VEEV - Free Report) recently announced that global pharmaceutical company Boehringer Ingelheim has decided to make a rapid shift to digital engagement standardizing on Veeva CRM Engage Meeting. This is expected to accelerate more valued virtual interactions between Boehringer Ingelheim’s global field organization and healthcare providers (“HCPs”). Notably, the Veeva’s CRM solution helped Boehringer Ingelheim host more than one million remote meetings in just a year.
The standardizing of Veeva CRM Engage Meeting by Boehringer Ingelheim builds upon the successful utilization of Veeva CRM for multichannel engagement. Also, the company uses Veeva Vault PromoMats and Veeva Vault MedComms to make compliant digital content used by field teams during engagements with HCPs.
The recent development is likely to boost Veeva’s CRM portfolio.
More in the News
Boehringer Ingelheim leverage Veeva CRM Engage Meeting to simplify compliant virtual meetings, extending the reach and productivity of its field team as well as provide them more flexibility to connect with HCPs anytime, anywhere. The adoption of Veeva CRM solution will enable Boehringer Ingelheim to adapt to new market dynamics and connect with the HCPs at the right time through the accurate channels.
Per management of Boehringer Ingelheim, Veeva CRM Engage Meeting provides an improved way to connect with doctors and provide them with the information related to new therapeutic options.
Notably, Veeva CRM Engage Meeting helped Boehringer Ingelheim convey more information to HCPs and strengthen relationships by doubling the medical sales representatives’ average meeting duration to 20 minutes during the past year.
Notable Developments
In March 2021, Veeva announced that it had its first patient complete an electronic consent for an early phase clinical trial at the Crofoot Research Center using Veeva eConsent, a MyVeeva for Patients application developed on Veeva Clinical Network.
In February 2021, Veeva announced that Veeva CRM and Veeva Vault PromoMats were adopted by Reckitt Benckiser, a leading provider of consumer hygiene, health, and nutrition products to accelerate its global digital transformation. Veeva CRM and Vault PromoMats enable Reckitt Benckiser to incorporate multichannel engagement and content to progress its commercial strategy as well as accelerate digital excellence around the globe.
Industry Prospects
Per a report by Grand View Research, the global healthcare CRM market size is expected to reach $17.8 billion by 2025 at a CAGR of 9.1%. Demand for operational efficiency in healthcare organization and adoption of virtual care is driving the market.
Price Performance
Shares of the company have gained 89.4% in a year’s time compared with the industry’s growth of 109.9%.
Zacks Rank and Key Picks
Currently, Veeva carries a Zacks Rank #2 (Buy).
Some other similar-ranked stocks from the broader medical space include Arlo Technologies, Inc. (ARLO - Free Report) , Calix, Inc (CALX - Free Report) and Covetrus, Inc. . You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Arlo Technologies has a projected long-term earnings growth rate of 48%.
Calix has a projected long-term earnings growth rate of 39%.
Covetrus has an estimated long-term earnings growth rate of 21%.
Zacks Names “Single Best Pick to Double”
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
You know this company from its past glory days, but few would expect that it’s poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>